Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.

Alicia B CarverAutumn D ZuckermanJoshua DeClercqLeena ChoiCody A Chastain

Published in: Open forum infectious diseases (2020)

Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.

Keyphrases

end stage renal disease
hiv infected
newly diagnosed
ejection fraction
chronic kidney disease
antiretroviral therapy
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes
smoking cessation
loop mediated isothermal amplification